clavulanic acid has been researched along with moxalactam in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (42.86) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 3 (21.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aubert, D; Naas, T; Nordmann, P; Ozcan, A | 1 |
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Girlich, D; Nordmann, P; Poirel, L | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Jehl, F; Monteil, H | 1 |
Carlisle, P; D'Olimpio, JT; McKitrick, JC; Miller, M; Sheridan, CA; Wiernik, PH; Wollner, DI | 1 |
Inoue, M; Kakizawa, H; Minami, S; Mitsuhashi, S; Saikawa, I; Takai, A; Yasuda, T; Yotsuji, A | 1 |
Bansal, MB; Chuah, SK; Lou, MA; Rao, B; See, RC; Thadepalli, H | 1 |
Timmes, JJ | 1 |
Kopp, PE; Siebert, WT | 1 |
He, L; Ke, H; Yuan, Q | 1 |
4 trial(s) available for clavulanic acid and moxalactam
Article | Year |
---|---|
A comparative trial of moxalactam plus ticarcillin and clavulanic acid or piperacillin as empiric antibiotic therapy for febrile cancer patients.
Topics: Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Neoplasms; Penicillins; Piperacillin; Ticarcillin | 1987 |
Ticarcillin plus clavulanic acid versus moxalactam in the treatment of skin and soft tissue infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cellulitis; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Female; Humans; Male; Middle Aged; Moxalactam; Penicillins; Skin Diseases, Infectious; Ticarcillin | 1985 |
Comparative study of ticarcillin plus clavulanate potassium and moxalactam in the treatment of surgical infections of the soft tissue.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Evaluation; Female; Humans; Male; Middle Aged; Moxalactam; Penicillins; Surgical Wound Infection; Ticarcillin | 1985 |
Ticarcillin plus clavulanic acid versus moxalactam therapy of osteomyelitis, septic arthritis, and skin and soft tissue infections.
Topics: Adult; Arthritis, Infectious; Bacterial Infections; Cellulitis; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Female; Humans; Male; Middle Aged; Moxalactam; Osteomyelitis; Penicillins; Skin Diseases, Infectious; Ticarcillin | 1985 |
10 other study(ies) available for clavulanic acid and moxalactam
Article | Year |
---|---|
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
Topics: beta-Lactamases; Chromosomes; Chromosomes, Bacterial; Citrobacter; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genes, Bacterial; Molecular Sequence Data | 2007 |
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Fresh Water; Gram-Negative Bacteria; Health Surveys; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas fluorescens; Water Microbiology | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
Topics: Anti-Bacterial Agents; Azlocillin; Cefoperazone; Ceftazidime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas; Ticarcillin | 1987 |
Cephamycin inactivation due to enzymatic hydrolysis by beta-lactamase from Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Cephamycins; Clavulanic Acid; Clavulanic Acids; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Penicillin G | 1985 |
A potential substrate binding conformation of β-lactams and insight into the broad spectrum of NDM-1 activity.
Topics: beta-Lactamases; beta-Lactams; Catalytic Domain; Clavulanic Acid; Klebsiella pneumoniae; Moxalactam; Protein Binding; Protein Conformation | 2012 |